SEC Form 4
Atea Pharmaceuticals, Inc. (AVIR) insider trading
In the 12 months to Nov 20, 2026, 2 AVIR insiders reported open-market sales of $319.8K across 3 filings; one director bought $50.9K.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $319.8K
- 3 filings · 2 insiders
- Open-market purchases
- $50.9K
- 2 filings · Polly A. Murphy, Director
Who traded AVIR, and when
- Purchase
- Sale
AVIR daily close from Nov 20, 2025 to Nov 20, 2026, between $2.97 and $6.15, last $4.00. 3 sale and 2 purchase filings by 3 insiders, marked at their filing dates. Bruce Polsky, Director: sold $203.4K across 2 filings, first filed Nov 18, 2026, last Nov 19, 2026. Bruno Lucidi, Director: sold $116.4K across 1 filing, first filed Nov 19, 2026, last Nov 19, 2026. Polly A. Murphy, Director: bought $50.9K across 2 filings, first filed May 20, 2026, last May 21, 2026.
Largest mark · tap a row for others
Bruce Polsky · Director
Filing 1 of 2 within a week · $203,393 total
Sale $168,095
41,226 shares at $4.08 avg
Filed Nov 18, 2026 · traded Nov 16
Close on filing date $3.99
Bruce Polsky · Director
Director
$203.4K soldBruno Lucidi · Director
Director
$116.4K soldPolly A. Murphy · Director
Director
$50.9K boughtOpen-market trades
5 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Bruce Polsky | Director | $203.4K | — | 2 | — | |
| Bruno Lucidi | Director | $116.4K | — | 1 | — | |
| Polly A. Murphy | Director | — | $50.9K | 2 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Bruce Polsky Director | Sale | 8,750 | $4.03 | $35.3K | 149,830 | |
traded | Bruno Lucidi Director | Sale | 29,360 | $3.96 | $116.4K | 187,990 | |
traded | Bruce Polsky Director | Sale | 41,226 | $4.08 | $168.1K | 158,580 | |
traded | Polly A. Murphy Director | Purchase | 6,100 | $4.17 | $25.4K | 92,145 | |
traded | Polly A. Murphy Director | Purchase | 6,100 | $4.17 | $25.4K | 92,145 |
GET /stocks/filings/vX/form-4?tickers=AVIR&filing_date.gte=2025-11-20&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"AVIR"
],
"issuer_cik": "0001593899",
"owner_cik": "0001508458",
"accession_number": "0001193125-26-469037",
"form_type": "4",
"filing_date": "2026-11-19",
"period_of_report": "2026-11-19",
"issuer_name": "Atea Pharmaceuticals, Inc.",
"issuer_trading_symbol": "AVIR",
"owner_name": "Polsky Bruce",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-11-19",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 8750,
"transaction_price_per_share": 4.0341,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 149830,
"transaction_value": 35298.37499999999,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $4.00 to $4.04. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote."
}
],
"remarks": "All sale transactions reported herein were executed to pay the exercise price of the options and for the Reporting Person's tax planning purposes."
},
{
"tickers": [
"AVIR"
],
"issuer_cik": "0001593899",
"owner_cik": "0001829622",
"accession_number": "0001193125-26-469038",
"form_type": "4",
"filing_date": "2026-11-19",
"period_of_report": "2026-11-17",
"issuer_name": "Atea Pharmaceuticals, Inc.",
"issuer_trading_symbol": "AVIR",
"owner_name": "Lucidi Bruno",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-11-17",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 6741,
"transaction_price_per_share": 4.0335,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 157237,
"transaction_value": 27189.823500000002,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $4.00 to $4.10. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote."
}
],
"remarks": "All sale transactions reported herein were executed to pay the exercise price of the options and for the Reporting Person's tax planning purposes."
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 25 records
- Option exercises19 records
- Tax withholding6 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Atea Pharmaceuticals, Inc.'s CEO sold stock?
No. Jean-Pierre Sommadossi (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is AVIR’s insider data?
These are AVIR Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track AVIR insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for AVIR every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.